Deciphering Breast Cancer: Spatial and Molecular Insights

28 Oct 2025 10:00 UTC

United States

Webinar

ソリューションを探す

In recognition of Breast Cancer Awareness Month, join us for a live webinar to uncover the complexity of tumor biology and the surprising resilience of normal tissue. This event will feature two expert-led presentations: one demonstrating how protein multiplexing and quantitative imaging uncover the hidden heterogeneity of breast tumors, and another examining how natural tissue remodeling can both suppress and influence oncogenic transformation. A live discussion and Q&A session will follow, giving you the opportunity to engage directly with leading researchers and gain valuable insights to improve cancer diagnosis, guide therapy decisions, and inform prevention strategies. All sessions will be available on demand, allowing flexible access for continued learning and engagement.


Moderated by: Andrea Radtke, PhD


Featured Talks:

Mapping Breast Cancer Heterogeneity with Protein Multiplexing and Quantitative Imaging

Presented by Alison Cheung, PhD

Learn how protein multiplexing and quantitative imaging reveal breast cancer heterogeneity at the single-cell level, enhancing diagnostic precision and informing treatment strategies through spatial biology and whole-mount histopathology techniques.


Natural tissue remodeling as trigger for breast tumor initiation? 

Presented by Colinda Scheele, PhD

Explore how natural breast tissue remodeling during reproductive stages influences the behavior of oncogenic cells, revealing intrinsic resistance mechanisms and molecular pathways that may impact breast cancer initiation and risk..


Learning Objectives:

  • Explore how protein multiplexing and quantitative imaging enable single-cell resolution analysis of breast cancer subtypes, revealing inter- and intra-tumoral diversity.
  • Learn how reproductive life stages and mammary epithelium remodeling impact the fate of oncogenic clones and influence breast cancer risk.
  • Discuss • Assess how spatial biology and tissue-intrinsic resistance mechanisms can guide biomarker discovery, refine therapeutic strategies, and improve clinical outcomes.


Register now to secure your spot and discover new insights that can strengthen diagnostic precision, inform therapy selection, and drive innovation in cancer research.

Scroll to top